Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MILES-3 phase III trial of cisplatin + gemcitabine versus gemcitabine alone in elderly patients with advanced non-small cell lung cancer
2009-013540-36Phase 3Completed
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing Gemcitabine alone with Cisplatin + gemcitabine (2 arms). Primary endpoint: Overall survival. Started Aug 2009; status: completed.
02
Drugs
cisplatingemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2009-013540-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013540-36.